Table 1.
Baseline Characteristics of the 11 Patients Enrolled in the Study
| Characteristic | Patients | ||
|---|---|---|---|
| n | % | ||
| Age, years | Median (range) | 65 (35–79) | – |
| Sex | Male | 8 | 73 |
| Female | 3 | 27 | |
| ECOG performance status | 0 | 11 | 100 |
| Cancer types | Gastric or gastro-esophageal | 6 | 55 |
| Colorectal | 4 | 36 | |
| Esophageal | 1 | 9 | |
| Pancreas | 1 | 9 | |
| Microsatellite instability status | Microsatellite stable | 9 | 82 |
| Unknown | 2 | 18 | |
| Previous treatment line | Median (range) | 5 (2–11) | – |
| Previous anti-PD1/PDL1 | Yes | 4 | 36 |
| Metastatic sites | Lymph node | 8 | 73 |
| Lung | 5 | 45 | |
| Liver | 4 | 36 | |
ECOG Eastern Cooperative Oncology Group